Jingjing Zhang

TL;DR: By using the WGCNA, new insights are provided into the underlying molecular mechanism and molecular markers correlated with HF development following an AMI, which may serve to improve risk stratification, therapeutic decisions, and prognosis prediction in AMI patients.

TL;DR: The intracoronary administration of anisodamine appears to improve myocardial reperfusion, cardiac function, and clinical outcomes in patients with STEMI undergoing PPCI.

TL;DR: Experimental data indicate that ASP protects the heart against ischemic injury by activating ATF6 to ameliorate the detrimental ER stress, and the associations between A. sinensis and AMI through multiple targets and several key signaling pathways are revealed.

TL;DR: Findings indicate that ASP, a major water-soluble component of A. sinensis, exerts protective effects against H2O2-induced injury in H9c2 cells by activating the ATF6 pathway, thus ameliorating ER and oxidative stress.

TL;DR: Patients with ACS can be readily stratified into distinct prognostic categories using the C ART risk stratification tool on the basis of CBC components, and the combined use of the CART risk categories and GRACE scores yielded a more accurate predictive value for MACEs.